This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Puder, J. J. Articles by Wardlaw, S. L. Search for Related Content PubMed PubMed Citation Articles by Puder, J. J. Articles by Wardlaw, S. L.

Estrogen Modulates the Hypothalamic-Pituitary-Adrenal and Inflammatory Cytokine Responses to Endotoxin in Women¹

Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032

Address all correspondence and requests for reprints to: Dr. Sharon L. Wardlaw, Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032. E-mail: sw22{at}columbia.edu

Abstract

Endotoxin stimulates the release of the inflammatory cytokines interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-, which are potent activators of the hypothalamic-pituitary-adrenal (HPA) axis. Recent studies in the rodent and in the primate have shown that the HPA responses to endotoxin and IL-1 were enhanced by gonadectomy and attenuated by estradiol (E2) replacement. In addition, there is some evidence, in the rodent, that estrogen modulates inflammatory cytokine responses to endotoxin. To determine whether estrogen has similar effects in humans, we studied the cytokine and HPA responses to a low dose of endotoxin (2–3 ng/kg) in six postmenopausal women with and without transdermal E2 (0.1 mg) replacement. Mean E2 levels were 7.3 ± 0.8 pg/mL in the unreplaced subjects and increased to 102 ± 13 pg/mL after estrogen replacement. Blood was sampled every 20 min for 1–2 h before, and for 7 h after, iv endotoxin administration. Endotoxin stimulated ACTH, cortisol, and cytokine release in women with and without E2 replacement. E2 significantly attenuated the release of ACTH (P < 0.0001) and of cortisol (P = 0.02). Mean ACTH levels peaked at 190 ± 91 pg/mL in the E2-replaced group vs. 411 ± 144 pg/mL in the unreplaced women, whereas the corresponding mean cortisol levels peaked at 27 ± 2.9 µg/dL with E2 vs. 31 ± 3.2 µg/dL without E2. Estrogen also attenuated the endotoxin-induced release of IL-6 (P = 0.02), IL-1 receptor antagonist (P = 0.003), and TNF- (P = 0.04). Mean cytokine levels with and without E2 replacement peaked at 341 ± 94 pg/mL vs. 936 ± 620 pg/mL for IL-6, 82 ± 14 ng/mL vs. 133 ± 24 ng/mL for IL-1 receptor antagonist, and 77 ± 46 pg/mL vs. 214 ± 87 pg/mL for TNF-, respectively. We conclude that inflammatory cytokine and HPA responses to a low dose of endotoxin are attenuated in postmenopausal women receiving E2 replacement. These data show, for the first time in the human, that a physiological dose of estrogen can restrain cytokine and neuroendocrine responses to an inflammatory challenge.

This article has been cited by other articles:

				O. T Wolf and B. M Kudielka Stress, health and ageing: a focus on postmenopausal women Menopause Int, September 1, 2008; 14(3): 129 - 133. [Abstract] [Full Text] [PDF]

				J. L. Sperry and J. P. Minei Gender dimorphism following injury: making the connection from bench to bedside J. Leukoc. Biol., March 1, 2008; 83(3): 499 - 506. [Abstract] [Full Text] [PDF]

				R. H. Straub The Complex Role of Estrogens in Inflammation Endocr. Rev., August 1, 2007; 28(5): 521 - 574. [Abstract] [Full Text] [PDF]

				B. W. Timmons, M. J. Hamadeh, and M. A. Tarnopolsky No effect of short-term 17beta-estradiol supplementation in healthy men on systemic inflammatory responses to exercise Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R285 - R290. [Abstract] [Full Text] [PDF]

				N. R. Vulliemoz, E. Xiao, L. Xia-Zhang, M. Ferin, and S. L. Wardlaw Melanocortin Modulation of Inflammatory Cytokine and Neuroendocrine Responses to Endotoxin in the Monkey Endocrinology, April 1, 2006; 147(4): 1878 - 1883. [Abstract] [Full Text] [PDF]

				J. J. Puder, S. Varga, M. Kraenzlin, C. De Geyter, U. Keller, and B. Muller Central Fat Excess in Polycystic Ovary Syndrome: Relation to Low-Grade Inflammation and Insulin Resistance J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6014 - 6021. [Abstract] [Full Text] [PDF]

				B. W. Timmons, M. J. Hamadeh, M. C. Devries, and M. A. Tarnopolsky Influence of gender, menstrual phase, and oral contraceptive use on immunological changes in response to prolonged cycling J Appl Physiol, September 1, 2005; 99(3): 979 - 985. [Abstract] [Full Text] [PDF]

				Y. Huang, S. Cao, M. Nagamani, K. E. Anderson, J. J. Grady, and L.-J. W. Lu Decreased Circulating Levels of Tumor Necrosis Factor-{alpha} in Postmenopausal Women during Consumption of Soy-Containing Isoflavones J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3956 - 3962. [Abstract] [Full Text] [PDF]

				C. A. Blum, B. Muller, P. Huber, M. Kraenzlin, C. Schindler, C. De Geyter, U. Keller, and J. J. Puder Low-Grade Inflammation and Estimates of Insulin Resistance during the Menstrual Cycle in Lean and Overweight Women J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3230 - 3235. [Abstract] [Full Text] [PDF]

				R. G. Smith, L. Betancourt, and Y. Sun Molecular Endocrinology and Physiology of the Aging Central Nervous System Endocr. Rev., April 1, 2005; 26(2): 203 - 250. [Abstract] [Full Text] [PDF]

				M. G. Flynn, B. K. McFarlin, M. D. Phillips, L. K. Stewart, and K. L. Timmerman Toll-like receptor 4 and CD14 mRNA expression are lower in resistive exercise-trained elderly women J Appl Physiol, November 1, 2003; 95(5): 1833 - 1842. [Abstract] [Full Text] [PDF]

				A. Mouihate and Q. J. Pittman Neuroimmune Response to Endogenous and Exogenous Pyrogens Is Differently Modulated by Sex Steroids Endocrinology, June 1, 2003; 144(6): 2454 - 2460. [Abstract] [Full Text] [PDF]

				R. E. Landman, J. J. Puder, E. Xiao, P. U. Freda, M. Ferin, and S. L. Wardlaw Endotoxin Stimulates Leptin in the Human and Nonhuman Primate J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1285 - 1291. [Abstract] [Full Text] [PDF]

				A. Beishuizen and L. G. Thijs Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis Innate Immunity, February 1, 2003; 9(1): 3 - 24. [Abstract] [PDF]

				A. Mouihate, M-S. Clerget-Froidevaux, K. Nakamura, M. Negishi, J. L. Wallace, and Q. J. Pittman Suppression of fever at near term is associated with reduced COX-2 protein expression in rat hypothalamus Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R800 - R805. [Abstract] [Full Text] [PDF]

				T. A. Elhadd, T. A.M. Abdu, and R. N. Clayton Excess Vascular Mortality in Hypopituitarism: Is it the Result of Estrogen or GH Deficiency? J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3509 - 3509. [Full Text] [PDF]

				J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF]

				E. Xiao, L. Xia-Zhang, M. Ferin, and S. L. Wardlaw Differential Effects of Estradiol on the Adrenocorticotropin Responses to Interleukin-6 and Interleukin-1 in the Monkey Endocrinology, July 1, 2001; 142(7): 2736 - 2741. [Abstract] [Full Text] [PDF]